HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Yamasaki Selected Research

Tyrosine Kinase Inhibitors

9/2021Clinical significance of surgical intervention for imatinib-resistant gastrointestinal stromal tumors in the era of multiple tyrosine kinase inhibitors.
1/2020TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Yamasaki Research Topics

Disease

93Neoplasms (Cancer)
07/2022 - 01/2007
91Esophageal Neoplasms (Esophageal Cancer)
09/2022 - 09/2007
61Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2007
45Esophageal Squamous Cell Carcinoma
09/2022 - 01/2007
25Neoplasm Metastasis (Metastasis)
02/2022 - 05/2007
12Body Weight (Weight, Body)
06/2022 - 04/2010
12Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022 - 10/2011
10Wounds and Injuries (Trauma)
10/2022 - 11/2012
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 05/2007
7Hemorrhage
04/2022 - 02/2012
7Inflammation (Inflammations)
10/2021 - 09/2011
7Lymphatic Metastasis
01/2019 - 02/2008
6Infections
04/2022 - 01/2016
5Weight Loss (Weight Reduction)
06/2022 - 07/2010
5Vomiting
01/2021 - 08/2012
5Neutropenia
12/2019 - 06/2004
5Adenocarcinoma
09/2016 - 07/2011
4Pneumonia (Pneumonitis)
06/2022 - 12/2019
4Diarrhea
01/2022 - 01/2017
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2008
4Squamous Cell Neoplasms (Squamous Cell Cancer)
11/2021 - 11/2010
4Residual Neoplasm
01/2020 - 07/2009
4Disease Progression
08/2015 - 01/2013
3Pancreatic Fistula (Pancreatic Fistulas)
06/2022 - 05/2013
3Lung Neoplasms (Lung Cancer)
11/2021 - 10/2014
3Body Weight Changes
01/2021 - 06/2012
3Pain (Aches)
01/2021 - 10/2013
3Abdominal Pain (Pain, Abdominal)
11/2018 - 02/2015
3Gastroesophageal Reflux (GERD)
01/2018 - 12/2016
3Malnutrition (Nutritional Deficiencies)
12/2015 - 04/2013
3Anorexia
12/2015 - 08/2012
3Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
08/2015 - 11/2011
3Nausea
04/2013 - 08/2012
2Febrile Neutropenia
01/2022 - 12/2019
2Sarcopenia
11/2021 - 12/2019
2Neoplasm Micrometastasis
01/2021 - 05/2007
2Peptic Esophagitis (Reflux Esophagitis)
01/2021 - 04/2013
2Aspiration Pneumonia
09/2020 - 01/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 03/2007
2Deglutition Disorders (Dysphagia)
12/2019 - 02/2013
2Esophageal Perforation
12/2019 - 09/2012
2Obesity
10/2019 - 03/2019

Drug/Important Bio-Agent (IBA)

25Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2009
18Docetaxel (Taxotere)FDA Link
01/2022 - 10/2009
17GhrelinIBA
06/2022 - 04/2010
17Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 07/2009
13Proteins (Proteins, Gene)FDA Link
04/2022 - 11/2008
11Imatinib Mesylate (Gleevec)FDA Link
02/2022 - 10/2011
7Indicators and Reagents (Reagents)IBA
06/2022 - 12/2015
7Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2012
7Biological ProductsIBA
03/2019 - 02/2008
6C-Reactive ProteinIBA
10/2021 - 11/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 07/2009
5Paclitaxel (Taxol)FDA LinkGeneric
12/2017 - 06/2004
5AntigensIBA
02/2017 - 11/2008
5MicroRNAs (MicroRNA)IBA
07/2016 - 05/2011
5Messenger RNA (mRNA)IBA
11/2014 - 02/2012
4NivolumabIBA
07/2022 - 11/2018
4VaccinesIBA
05/2017 - 11/2008
4Cancer VaccinesIBA
05/2017 - 11/2008
3Hemostatics (Antihemorrhagics)IBA
10/2022 - 10/2020
3DNA (Deoxyribonucleic Acid)IBA
06/2022 - 09/2016
3Pharmaceutical PreparationsIBA
11/2021 - 01/2020
3AntibodiesIBA
07/2021 - 07/2012
3Interleukin-6 (Interleukin 6)IBA
09/2019 - 08/2015
3Hemoglobins (Hemoglobin)IBA
05/2018 - 06/2004
3Sunitinib (Sutent)FDA Link
01/2018 - 10/2011
3N-(4-isothiocyanatophenethyl)spiperoneIBA
01/2012 - 11/2011
2Hormones (Hormone)IBA
06/2022 - 04/2012
2Lipoprotein Receptors (Lipoprotein Receptor)IBA
10/2021 - 08/2018
2AmylasesFDA Link
10/2021 - 11/2017
2Tyrosine Kinase InhibitorsIBA
09/2021 - 01/2020
2Keratins (Keratin)IBA
01/2021 - 05/2007
2LipopolysaccharidesIBA
01/2021 - 09/2019
2Hematoxylin (Haematoxylon)IBA
01/2020 - 05/2007
2Eosine Yellowish-(YS) (Eosin)IBA
01/2020 - 05/2007
2Fibrinogen (Factor I)FDA Link
01/2020 - 08/2016
2SteroidsIBA
10/2019 - 11/2013

Therapy/Procedure

64Drug Therapy (Chemotherapy)
01/2022 - 05/2007
48Neoadjuvant Therapy
01/2022 - 05/2007
41Esophagectomy
09/2022 - 09/2007
39Gastrectomy
06/2022 - 11/2009
35Therapeutics
02/2022 - 01/2007
17Chemoradiotherapy
09/2022 - 09/2007
11Lymph Node Excision (Lymph Node Dissection)
01/2019 - 01/2007
6Combination Drug Therapy (Combination Chemotherapy)
05/2016 - 04/2010
5Enteral Nutrition (Feeding, Tube)
01/2022 - 01/2012
5Radiotherapy
09/2020 - 11/2011
5Laparotomy
10/2019 - 07/2010
4Adjuvant Chemotherapy
01/2021 - 11/2008
4Aftercare (After-Treatment)
11/2018 - 06/2004
3Fundoplication
01/2019 - 11/2013
3Epidural Anesthesia
02/2016 - 10/2013
3Splenectomy
11/2015 - 11/2009
3Combined Modality Therapy
08/2015 - 07/2011
2Radiofrequency Ablation
02/2022 - 11/2014
2Operative Surgical Procedures
03/2021 - 04/2016
2Heart Transplantation (Grafting, Heart)
01/2021 - 01/2021
2Parenteral Nutrition
01/2021 - 01/2012
2Length of Stay
12/2019 - 10/2013